Bilateral Wilms tumour: a review of clinical and molecular features

被引:86
作者
Charlton, Jocelyn [1 ]
Irtan, Sabine [1 ,2 ]
Bergeron, Christophe [3 ]
Pritchard-Jones, Kathy [1 ]
机构
[1] UCL, UCL Inst Child Hlth, London, England
[2] Trousseau Hosp, Paediat Surg Dept, Paris, France
[3] Ctr Leon Berard, Inst Hematol & Oncol Pediat, Lyon, France
来源
EXPERT REVIEWS IN MOLECULAR MEDICINE | 2017年 / 19卷
基金
欧盟第七框架计划;
关键词
NEPHRON-SPARING SURGERY; SINGLE-CENTER EXPERIENCE; APPARENT DIFFUSION-COEFFICIENT; MOSAIC VARIEGATED ANEUPLOIDY; BECKWITH-WIEDEMANN-SYNDROME; CANCER-STUDY-GROUP; OF-THE-LITERATURE; ROUND-CELL TUMOR; BETA-CATENIN; IMAGING CHARACTERISTICS;
D O I
10.1017/erm.2017.8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Wilms tumour (WT) is the most common paediatric kidney cancer and affects approximately one in 10 000 children. The tumour is associated with undifferentiated embryonic lesions called nephrogenic rests (NRs) or, when diffuse, nephroblastomatosis. WT or NRs can occur in both kidneys, termed bilateral disease, found in only 5-8% of cases. Management of bilateral WT presents a major clinical challenge in terms of maximising survival, preserving renal function and understanding underlying genetic risk. In this review, we compile clinical data from 545 published cases of bilateral WT and discuss recent progress in understanding the molecular basis of bilateral WT and its associated precursor NRs in the context of the latest radiological, surgical and epidemiological features.
引用
收藏
页数:13
相关论文
共 81 条
[1]   Long-Term Outcome of Bilateral Wilms Tumors (BWT) [J].
Aronson, Daniel C. ;
Slaar, Annelie ;
Heinen, Richard C. ;
de Kraker, Jan ;
Heij, Hugo A. .
PEDIATRIC BLOOD & CANCER, 2011, 56 (07) :1110-1113
[2]  
BECKWITH J B, 1990, Pediatric Pathology, V10, P1
[3]  
Beckwith JB, 1998, AM J MED GENET, V79, P268, DOI 10.1002/(SICI)1096-8628(19981002)79:4<268::AID-AJMG7>3.0.CO
[4]  
2-I
[5]   Does nephroblastomatosis influence the natural history and relapse rate in Wilms' tumour? A single centre experience over 11 years [J].
Bergeron, C ;
Iliescu, C ;
Thiesse, P ;
Bouvier, R ;
Dijoud, F ;
Ranchere-Vince, D ;
Basset, T ;
Chappuis, JP ;
Buclon, M ;
Frappaz, D ;
Brunat-Mentigny, M ;
Philip, T .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (03) :385-391
[6]   EPIDEMIOLOGY OF WILMS-TUMOR [J].
BRESLOW, N ;
OLSHAN, A ;
BECKWITH, JB ;
GREEN, DM .
MEDICAL AND PEDIATRIC ONCOLOGY, 1993, 21 (03) :172-181
[7]   End stage renal disease in patients with Wilms tumor: Results from the National Wilms Tumor Study Group and the United States Renal Data System [J].
Breslow, NE ;
Collins, AJ ;
Ritchey, ML ;
Grigoriev, YA ;
Peterson, SM ;
Green, DM .
JOURNAL OF UROLOGY, 2005, 174 (05) :1972-1975
[8]   Characteristics and outcomes of children with the Wilms Tumor-Aniridia syndrome: A report from the National Wilms Tumor Study Group [J].
Breslow, NE ;
Norris, R ;
Norkool, PA ;
Kang, T ;
Beckwith, JB ;
Perlman, EJ ;
Ritchey, ML ;
Green, DM ;
Nichols, KE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4579-4585
[9]   A role for the Perlman syndrome exonuclease Dis3l2 in the Lin28-let-7 pathway [J].
Chang, Hao-Ming ;
Triboulet, Robinson ;
Thornton, James E. ;
Gregory, Richard I. .
NATURE, 2013, 497 (7448) :244-+
[10]   Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development [J].
Charles, AK ;
Brown, KW ;
Berry, PJ .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (03) :991-1000